摘要
目的:探讨Survivin在人非小细胞肺癌组织中表达、临床意义及其与VEGF表达的相关性。方法:采用免疫组织化学(Envision二步法)检测Survivin和VEGF在116例肺鳞癌、腺癌组织及15例肺良性病变组织中的表达情况。结果:Survivin、VEGF的阳性率分别为62.1%(72/116)、72.4%(84/116),显著高于肺良性病变组织的0(0/15)、13.3%(2/15);Survivin表达与非小细胞肺癌的低分化(P<0.05)、淋巴结转移呈正相关(P<0.05),与患者预后负相关(P<0.05);VEGF的表达与肺癌组织的分化程度、TNM分期及淋巴结转移均有关(P<0.05);并且Survivin表达与VEGF表达呈正相关(P<0.05)。结论:Survivin有望成为肺癌诊断和基因治疗的新靶点。
Objective: To investigate the expression of survivin and its correlation with VEGF in non-small cell lung cancer.Methods: The expression of survivin and VEGF were examined by using immunohistochemica1 staining(Envision two step method.Results: The positive expression rate of survivin and VEGF in NACLC and BPD was 62.1%(72/116),72.4 %(84/116)respectively,which was obviously higher than that in BPD.The expression of survivin was associated with the poor differentiation(P0.05) and lymph node metastasis(P0.05) respectively.However,it was negative correlated with the prognosis;The expression of VEGF was associated with the poor differentiation,TNM state and lymph node metastasis of lung cancer respective1y(P0.05).Besides,The expressions of surviving were corre1ated with VEGF each(P0.05).Condusion: Survivin gene may be identified as a defining diagnostic marker and a potential therapeutic target.
出处
《现代生物医学进展》
CAS
2011年第24期4864-4867,共4页
Progress in Modern Biomedicine